Evidence map›Paper›PMID 34459135›Full record

ArticleClinical and translational medicine2021

A biobanking turning-point in the use of formalin-fixed, paraffin tumor blocks to unveil kinase signaling in melanoma.

Erika Velasquez, Leticia Szadai, Qimin Zhou, Yonghyo Kim, Indira Pla, Aniel Sanchez, Roger Appelqvist, Henriett Oskolas, Matilda Marko-Varga, Boram Lee and 7 more

Abstract readLetter
In one paragraph

Article in Clinical and translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Erika VelasquezSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.ORCID 0000-0002-2169-3315
Leticia SzadaiDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungar.
Qimin ZhouDepartment of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yonghyo KimDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Indira PlaSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.ORCID 0000-0002-0839-7829
Aniel SanchezSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
Roger AppelqvistTreat4Life AB, Malmö, Sweden.
Henriett OskolasDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Matilda Marko-VargaTreat4Life AB, Malmö, Sweden.
Boram LeeTreat4Life AB, Malmö, Sweden.
Ho Jeong KwonChemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.ORCID 0000-0002-6919-833X
Johan MalmSection for Clinical Chemistry, Department of Translational Medicine, Lund University, Skåne University Hospital Malmö, Malmö, Sweden.
Attila Marcell SzászDepartment of Bioinformatics, Semmelweis University, Budapest, Hungary.
Jeovanis GilDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.ORCID 0000-0003-3601-3893
Lazaro Hiram BetancourtDivision of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.ORCID 0000-0001-8207-7041
István Balázs NémethDepartment of Dermatology and Allergology, University of Szeged, Szeged, Hungar.
György Marko-VargaChemical Genomics Global Research Lab, Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.

Funding

Berta Kamprad Foundation (European Cancer Moonshot Project; BKS17-22 and The Impact of Malignant Melanoma Tumor Heterogeneity on Drug Treatment Effects at Single Cell Level-a Prospective ProteoGenomic & Digital Pathology Study).National Research Foundation of Korea 2015K1A1A2028365National Research Foundation of Korea 2016K2A9A1A03904900Swedish Pharmaceutical Society (Early Career Post-Doc Program: 020-022)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological Specimen BanksHumansMelanomaParaffin EmbeddingPhosphotransferasesSignal TransductionTissue FixationPhosphotransferases

Identifiers

PMID34459135
PMCPMC8335964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.